 The absolute configuration of perrottetinene was established in 2008 by an enantioselective total synthesis.In 2018, a study showed that perrottetinene is moderately psychoactive through activation of the cannabinoid receptor 1.The same study also reported reduced prostaglandin D2 and E2 brain concentrations in mice after perrottetinene administration.